These findings are in line with the literature, where a high expression of EGFR is associated with PC progression [22,32,33], and a low ERBB3 expression, located in the nucleus, is associated with a worse prognosis [27] and an increased risk of BCR. The gene discussed is EGFR; the disease is pachyonychia congenita.